The U.S. Agency for International Development has awarded ICF (Nasdaq: ICFI) a potential five-year, $120 million task order to help USAID’s Bureau for Global Health develop infectious disease surveillance measures for lower and middle-income countries.
ICF said Monday it will assist developing countries in efforts to modernize national diagnostic networks, laboratory systems and disease-monitoring mechanisms under the task order awarded through the General Services Administration’s OASIS contract vehicle.
“We are excited about this opportunity to work in partnership with USAID and focal countries to strengthen diagnostic networks, surveillance systems and capacity to detect anti-microbial resistance,” said Leo Ryan, a senior vice president of ICF.
Speaking with GovConDaily Tuesday, Ryan added, “Disease detection and surveillance systems are critical to public health at the local, national and global levels. Data-backed insights into the emergence of infectious disease empower public health officials to more quickly contain outbreaks, and lead to informed policy decisions.”
The company will perform work in support of the U.S. government’s Global Health Security Agenda, which aims to improve countries’ capacity to thwart contagious illnesses.
The order has one base year and four option years.